Related Experiment Videos
[Venous thrombosis in pregnancy].
1Venenzentrum Frankfurt am Main. Hach-Wunderle@t-online.de
VASA. Zeitschrift Fur Gefasskrankheiten
|August 30, 2003
Summary
Pulmonary embolism (PE) is a leading cause of maternal death, often stemming from deep vein thrombosis. Early diagnosis via imaging and risk assessment through hemostasis testing guide heparin anticoagulation and compression therapy.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Vascular Medicine
Context:
- Pulmonary embolism (PE) is a significant cause of mortality in pregnant and postpartum women.
- Deep vein thrombosis (DVT) in the legs and pelvis is the primary etiology of PE.
- Advances in medical imaging enable early and reliable diagnosis of PE.
Purpose:
- To outline the diagnostic approaches for pulmonary embolism during pregnancy and the puerperium.
- To discuss risk assessment strategies for thrombosis.
- To describe current treatment modalities for PE in this patient population.
Summary:
- Pulmonary embolism presents a critical risk during pregnancy and the puerperium, typically originating from deep vein thrombosis.
- Modern imaging techniques facilitate early diagnosis, while specialized hemostasis tests can identify individual thrombosis risks.
- Treatment primarily involves body weight-dependent heparin anticoagulation, supplemented by compression therapy when feasible.
Impact:
- Improved diagnostic accuracy leads to timely intervention for pulmonary embolism.
- Personalized risk assessment aids in preventative strategies for maternal thrombosis.
- Effective anticoagulation and compression therapies reduce mortality associated with PE in pregnant and postpartum women.